Mucin-1: a promising pan-cancer therapeutic target
Abstract Mucin1 or MUC1 (also known as CD227, EMA, MCD, MAM6, PEM, PUM, KL-6, CA 27.29/CA 15-3) is a highly glycosylated transmembrane mucin family member protein that is overexpressed in various solid or hematological cancers. Abnormal MUC1 expression/glycosylation in cancer leads to the activation...
Saved in:
| Main Authors: | Udhayvir Singh Grewal, Razelle Kurzrock |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-01016-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The multifaceted roles of mucins family in lung cancer: from prognostic biomarkers to promising targets
by: Qinghong Yuan, et al.
Published: (2025-06-01) -
The NLRP1 Emerges as a Promising Therapeutic Target and Prognostic Biomarker Across Multiple Cancer Types: A Comprehensive Pan‐Cancer Analysis
by: Leila Habibipour, et al.
Published: (2025-04-01) -
OncoAID: an open access targeted anti-cancer drugs database
by: Ohad Landau, et al.
Published: (2025-08-01) -
HMGB1: A Promising Therapeutic Target for Prostate Cancer
by: Munirathinam Gnanasekar, et al.
Published: (2013-01-01) -
Pan-cancer analysis identifies CD155 as a promising target for CAR-T cell therapy
by: Xiaohong Liu, et al.
Published: (2025-06-01)